These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3672299)

  • 1. A high plasma prostaglandin to thromboxane ratio protects against renal ischemia.
    Kaufman RP; Anner H; Kobzik L; Valeri CR; Shepro D; Hechtman HB
    Surg Gynecol Obstet; 1987 Nov; 165(5):404-9. PubMed ID: 3672299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostacyclin and thromboxane A2 moderate postischemic renal failure.
    Lelcuk S; Alexander F; Kobzik L; Valeri CR; Shepro D; Hechtman HB
    Surgery; 1985 Aug; 98(2):207-12. PubMed ID: 3895535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasodilating prostaglandins attenuate ischemic renal injury only if thromboxane is inhibited.
    Klausner JM; Paterson IS; Kobzik L; Rodzen C; Valeri CR; Shepro D; Hechtman HB
    Ann Surg; 1989 Feb; 209(2):219-24. PubMed ID: 2644899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
    Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
    J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the thromboxane A2 synthetase inhibitor OKY-046 in a warm ischemia-reperfusion rat model.
    Garvin PJ; Niehoff ML; Robinson SM; Heisler T; Salinas-Madrigal L; Contis J; Solomon H
    Transplantation; 1996 May; 61(10):1429-34. PubMed ID: 8633364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasodilator prostaglandins (PG) prevent renal damage after ischemia.
    Kaufman RP; Anner H; Kobzik L; Valeri CR; Shepro D; Hechtman HB
    Ann Surg; 1987 Feb; 205(2):195-8. PubMed ID: 3813690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of endotoxin-induced pulmonary hypertension in primates by the use of a selective thromboxane synthetase inhibitor, OKY 1581.
    Casey LC; Fletcher JR; Zmudka MI; Ramwell PW
    J Pharmacol Exp Ther; 1982 Aug; 222(2):441-6. PubMed ID: 6896528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the infusion of OKY-046, a thromboxane A2 synthase inhibitor, on urinary metabolites of prostacyclin and thromboxane A2 in healthy human subjects.
    Morio H; Hirai A; Terano T; Tamura Y; Yoshida S
    Thromb Haemost; 1993 Mar; 69(3):276-81. PubMed ID: 8470052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion of prostaglandins and renal function after hepatic resection.
    Matsumata T; Yamamoto K; Shirabe K; Shimada M; Sugimachi K; Takesue F; Muto Y; Ikeda T
    Hepatogastroenterology; 1997; 44(15):774-8. PubMed ID: 9222688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combined use of prostaglandin I2 analogue (OP-2507) and thromboxane A2 synthetase inhibitor (OKY-046) strongly inhibits atherosclerosis of aortic allografts in rats.
    Hirano T; Nakafusa Y; Kawano R; Motoyama K; Arima T; Sugitani A; Tanaka M
    Surgery; 2001 May; 129(5):595-605. PubMed ID: 11331452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of thromboxane A2 synthesis inhibitor (OKY-046) on total liver ischemia in rats.
    Kobayashi T; Esato K; Morita N; Noshima NS
    Int Surg; 1996; 81(2):115-8. PubMed ID: 8912073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of thromboxane (Tx) synthesis by free radical scavengers.
    Kaufman RP; Klausner JM; Anner H; Feingold H; Kobzik L; Valeri CR; Shepro D; Hechtman HB
    J Trauma; 1988 Apr; 28(4):458-64. PubMed ID: 3127599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of selective inhibition of thromboxane synthesis on renal function in diabetic nephropathy.
    Kontessis PS; Jones SL; Barrow SE; Stratton PD; Alessandrini P; De Cosmo S; Ritter JM; Viberti GC
    J Lab Clin Med; 1993 Mar; 121(3):415-23. PubMed ID: 8445289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.
    Yui Y; Hattori R; Takatsu Y; Nakajima H; Wakabayashi A; Kawai C; Kayama N; Hiraku S; Inagawa T; Tsubojima M
    Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dietary n-3 fatty acid supplementation versus thromboxane synthetase inhibition on gentamicin-induced nephrotoxicosis in healthy male dogs.
    Grauer GF; Greco DS; Behrend EN; Fettman MJ; Mani I; Getzy DM; Reinhart GA
    Am J Vet Res; 1996 Jun; 57(6):948-56. PubMed ID: 8725828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a thromboxane synthetase inhibitor (OKY-046) in an ischemia-reperfusion model of intrauterine growth retardation in Sprague-Dawley rats.
    Tanaka M; Natori M; Ishimoto H; Miyakoshi K; Miyazaki T; Kobayashi T; Yoshimura Y
    Biol Neonate; 1997; 72(3):181-6. PubMed ID: 9303217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of thromboxane synthetase inhibition on postburn mesenteric vascular resistance and the rate of bacterial translocation in a chronic porcine model.
    Tokyay R; Loick HM; Traber DL; Heggers JP; Herndon DN
    Surg Gynecol Obstet; 1992 Feb; 174(2):125-32. PubMed ID: 1734570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tetrodotoxin and OKY-046 in renal ischemia reperfusion.
    Garvin PJ; Niehoff ML; Robinson SM
    J Surg Res; 1999 Aug; 85(2):273-8. PubMed ID: 10423329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemia of the limb stimulates thromboxane production and myocardial depression.
    Mathieson MA; Dunham BM; Huval WV; Lelcuk S; Stemp LI; Valeri CR; Shepro D; Hechtman HB
    Surg Gynecol Obstet; 1983 Dec; 157(6):500-4. PubMed ID: 6648769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of a selective cyclooxygenase-2 inhibitor on small bowel ischemia-reperfusion injury.
    Kawata K; Takeyoshi I; Iwanami K; Sunose Y; Tsutsumi H; Ohwada S; Matsumoto K; Morishita Y
    Hepatogastroenterology; 2003; 50(54):1970-4. PubMed ID: 14696445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.